Table II.
Comparisons of clinical data between NAFLD group and N-NAFLD group in PCOS group.
| Index | N-NAFLD group (n=104) | NAFLD group (n=84) | P-value |
|---|---|---|---|
| Age (years) | 25.16±5.07 | 27.32±6.15 | 0.007 |
| BMI (kg/m2) | 23.25±3.18 | 28.61±4.27 | >0.05 |
| WHR | 0.83±0.09 | 0.94±0.08 | >0.05 |
| LH (IU/l) | 8.41±5.36 | 10.56±9.05 | 0.061 |
| FSH (IU/l) | 7.36±2.79 | 7.13±3.09 | 0.523 |
| LH/FSH | 1.23±0.82 | 1.51±1.14 | 0.109 |
| T (nmol/l) | 2.19±0.78 | 2.17±0.89 | 0.513 |
| TG (mmol/l) | 0.93±0.14 | 1.66±0.22 | >0.05 |
| TC (mmol/l) | 4.38±1.04 | 4.78±0.91 | 0.029 |
| HDL (mmol/l) | 1.54±0.39 | 1.14±0.21 | >0.05 |
| DHEAs (µg/dl) | 228.56±111.84 | 219.75±98.46 | 0.478 |
| SHBG (nmol/l)a | 49.21 (40.47–57.69) | 24.16 (18.98–29.34) | >0.05 |
| FAI | 6.71 (5.35–7.98) | 13.97 (11.61–16.37) | >0.05 |
| FBG (mmol/l) | 4.74±0.43 | 5.02±0.46 | 0.002 |
| FINS (mIU/l)a | 8.79 (7.45–10.14) | 19.71 (16.56–22.82) | >0.05 |
| HOMA-IR | 1.90±0.32 | 4.83±0.84 | >0.05 |
| ALT (U/l)a | 13.37 (11.26–15.48) | 42.12 (35.04–49.20) | >0.05 |
a
Non-normal data.